The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
Clinical trial NCT00002389 · COMPLETED
Trial details
- NCT number
- NCT00002389
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.